We do our best work because we have created an inclusive and diverse environment that ensures our more than 32,000 global employees can be their authentic selves at work. We know that through inclusion and diversity, we strengthen the foundation of BMS and unleash our collective ability to realize the promise and power of science for all.
While this report amplifies our progress in 2021, it also serves as a means to hold ourselves accountable. We are accelerating our efforts to drive scientific innovation to meet the evolving needs of patients worldwide and drive sustainable business performance.
The need for the development of innovative treatments for serious diseases has never been greater. That urgency is a big part of why we are unrelenting in our pursuit to narrow health disparities. We are acutely aware of the role that access to our medicines can play in improving the lives of patients and their families, which is why we are doing all we can to ensure greater health equity.
